Curing the donor organ shortage with gene editing │ Dr. George Church
Get the full length version of this episode as a podcast.
This episode will make a great companion for a long drive.
The Omega-3 Supplementation Guide
A blueprint for choosing the right fish oil supplement — filled with specific recommendations, guidelines for interpreting testing data, and dosage protocols.
Xenotransplantation, the practice of transplanting an organ from a non-human animal, such as a pig or chimpanzee, to a human, has its origins in the 1960s. Among six patients receiving kidney xenotransplants from chimpanzees in 1963, one survived for nine months in moderate health. So far, the field has yet to overcome the problem of rejection of transplanted tissues by the immune system. However, with multiplex editing or genome writing, genetically engineered organs from pigs that resist rejection may revolutionize medicine. In this clip, Dr. George Church discusses how engineering animal organs may make them suitable for human transplant.
This transcript is reserved for members.
FoundMyFitness Members get access to exclusive content not available anywhere else, including a transcript of this episode.
You wouldn't believe how cool being a premium member of the world's best cross-disciplinary science-focused website and podcast really is.
Member only extras:
Learn more about the advantages of a premium membership by clicking below.
Supporting our work
If you enjoy the fruits of
, you can participate in helping us to keep improving it. Creating a premium subscription does just that! Plus, we throw in occasional member perks and, more importantly, churn out the best possible content without concerning ourselves with the wishes of any dark overlords.
Genetic engineering News
- Vitamin B12 supports metabolic processes involved in stem cell reprogramming and tissue repair.
- Ovarian cancer tumors, even at advanced stages, may be effectively targeted and eliminated by CAR-T immune therapies, a new study in mice suggests.
- ‘Gene silencing’ therapy reduces lipoprotein(a), an important risk factor of heart disease, by up to 98%
- Gene therapy for thalassemia ends need for transfusions in young children
- Designer cytokine restores spinal cord function in mice.
